# SPOT: Sequential Predictive Modeling of Clinical Trial Outcome with Meta-Learning

**Authors:** Zifeng Wang, Cao Xiao, Jimeng Sun  
**arXiv:** [2304.05352](https://arxiv.org/abs/2304.05352)  
**Date:** 2023-04-07  
**Summary page:** https://www.summarizepaper.com/en/paper/2304.05352v1/

## Key points

- Clinical trials are crucial for drug development but can be time-consuming, expensive, and prone to failure.
- Accurate prediction of trial outcomes based on historical data is essential for making informed investment decisions and increasing success rates.
- Existing prediction models have limitations in capturing relationships among similar trials, tracking the evolution of trial features and designs, and addressing skewness in trial data.
- A new approach called Sequential Predictive mOdeling of clinical Trial outcome (SPOT) has been proposed to address these issues and provide more accurate predictions.
- SPOT first identifies trial topics to cluster multi-sourced trial data into relevant categories, then generates trial embeddings organized by topic and time to create sequences representing the progression of clinical trials.
- By treating each trial sequence as a task using meta-learning strategy, SPOT quickly adapts to new tasks with minimal updates for more accurate and interpretable predictions.
- Experimental results show that SPOT outperforms previous methods significantly across different phases of clinical trials, achieving a 21.5% improvement in phase I trials, an 8.9% lift in phase II trials, and a 5.5% lift in phase III trials based on the PR-AUC metric.
- Building topic-specific models is essential for accurately predicting trial outcomes as they often depend on specific events such as success or failure.
- SPOT's predicted probability distributions align closely with actual outcomes across different topics, offering a promising solution for enhancing clinical trial outcome predictions.

## Summary

, , , , 

Clinical trials are a crucial aspect of drug development, but they can be time-consuming, expensive, and prone to failure. Accurate prediction of trial outcomes based on historical data is essential for making informed investment decisions and increasing success rates. However, existing prediction models have limitations in capturing relationships among similar trials, tracking the evolution of trial features and designs, and addressing skewness in trial data. To address these issues and provide more accurate predictions, a new approach called Sequential Predictive mOdeling of clinical Trial outcome (SPOT) has been proposed. SPOT first identifies trial topics to cluster multi-sourced trial data into relevant categories. It then generates trial embeddings and organizes them by topic and time to create sequences that represent the progression of clinical trials. By treating each trial sequence as a task, SPOT utilizes a meta-learning strategy that allows the model to quickly adapt to new tasks with minimal updates. The incorporation of topic discovery enables a deeper understanding of the underlying structure of the data, while sequential learning captures the evolution of trial designs and outcomes over time. As a result, SPOT provides predictions that are not only more accurate but also more interpretable, taking into account temporal patterns and unique characteristics within each trial topic. Experimental results demonstrate that SPOT outperforms previous methods significantly on benchmark data for different phases of clinical trials. Specifically, SPOT achieves a 21.5% improvement in phase I trials, an 8.9% lift in phase II trials, and a 5.5% lift in phase III trials based on the area under precision-recall curve (PR-AUC) metric. Furthermore, sensitivity analysis reveals that building topic-specific models is essential for accurately predicting trial outcomes as they often depend on specific events such as success or failure. The predicted probability distributions generated by SPOT align closely with actual outcomes across different topics. In conclusion, this innovative approach offers a promising solution for enhancing clinical trial outcome predictions by capturing nuances in the data and providing valuable insights for future research in this field.